Number of shares and votes in medicover
The number of shares and votes in Medicover AB (publ) (“Medicover”) has changed as a result of the issue of new class B shares carried out in connection with the listing of Medicover’s class B shares on Nasdaq Stockholm on 23 May 2017.
Today, on the last trading day of the month, there are in total 133,335,195 shares in Medicover, of which 81,921,146 are class A shares, together carrying 81,921,146 votes, and 51,414,049 are class B shares, together carrying 5,141,404.9 votes. The total number of votes in Medicover is 87,062,550.9.
For further information, please contact:
Paula Treutiger, Director Corporate Communications & Investor Relations
Phone: +46 733 666 599
paula.treutiger@medicover.com
Medicover is required to publish the information contained in this press release pursuant to the Swedish Financial Instruments Trading Act. The information was provided for publication by the abovementioned contact person at 09.00 am CEST on 31 May, 2017.
About Medicover
Medicover is a leading international healthcare and diagnostic services provider in Poland, Germany, Romania, Ukraine and certain other markets, primarily in Central and Eastern Europe (“CEE”). Additionally, Medicover is in the process of entering the fast-growing Indian healthcare market in order to expand its geographical footprint and further leverage its emerging markets capabilities. Medicover offers a broad range of healthcare services and a significant hub-and-spoke diagnostic laboratory network, supported by extensively developed proprietary software and information systems infrastructure. Medicover operates through two divisions: Healthcare Services and Diagnostic Services.
Healthcare Services offers services ranging from primary care to specialist outpatient and inpatient healthcare. The division generated 49 percent of Medicover’s revenue in 2016, primarily through an integrated “subscription-provider” payment model, which is predominantly an employer funded employee benefit healthcare package. The Healthcare Services division operates over 100 medical centres in 7 countries, with 889 thousand members generating more than 4.9 million visits 2016.
Diagnostic Services offers a broad range of diagnostic laboratory services, including a broad range of routine and advanced tests across all major clinical pathology areas. In 2016, the division generated 51 percent of Medicover’s revenue, operated 91 laboratories and over 454 blood drawing points (“BDPs”), and conducted 115 million tests.
Since its inception in 1995, Medicover has seen its revenue grow every year and since 2006, it has grown almost seven-fold with organic growth accounting for over 70 percent of such growth. In 2016, Medicover’s revenue amounted to €497 million and adjusted EBITDA amounted to €46 million.